Sotera Health Company (SHC)
$
12.2
-0.23 (-1.89%)
Key metrics
Financial statements
Free cash flow per share
0.2649
Market cap
3.5 Billion
Price to sales ratio
3.1186
Debt to equity
0
Current ratio
2.4558
Income quality
9.6492
Average inventory
55.1 Million
ROE
0.0580
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Sotera Health Company specializes in sterilization, lab testing, and advisory services across the United States, Canada, Europe, and globally. The company incurred an interest expense of $164,691,000.00 reflecting its debt servicing obligations. Its sterilization offerings encompass gamma and electron beam irradiation, alongside ethylene oxide processing. Nelson Labs operates under the company umbrella, providing microbiological and analytical chemistry testing, while also rendering advisory services tailored for the medical device and biopharmaceutical sectors. The gross profit stands at $602,295,000.00 highlighting the company's profitability from core operations, and the gross profit ratio is $0.55 which reflects the efficiency of the company's production and sales endeavors. Sotera Health services a diverse range of industries, including medical devices, pharmaceuticals, food and agricultural products, as well as commercial, advanced, and specialty applications. The total costs and expenses for the company are $802,815,000.00 indicating its overall spending. Additionally, the earnings per share (EPS) is reported at $0.16 providing insight into the company's profitability on a per-share basis. Formerly known as Sotera Health Topco, Inc., the company changed its name to Sotera Health Company in October 2020 and was incorporated in 2017, establishing its headquarters in Broadview Heights, Ohio. In the present market, the stock is affordable at $12.20 making it an appealing option for budget-conscious investors. With a high average trading volume of 1,272,019.00 the stock indicates strong liquidity, enhancing its attractiveness to potential buyers. Moreover, with a mid-range market capitalization of $3,463,031,000.00 the company is recognized as a steady performer within the market. As a key player in the Medical - Diagnostics & Research industry, Sotera Health Company contributes significantly to the overall market landscape, driving innovation and growth. It belongs to the Healthcare sector, which further positions the company for ongoing development and success in its strategic endeavors.
Is Sotera Health Company (SHC) a good investment?
Investing in Sotera Health Company (SHC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bearish outlook. Always conduct your own research before investing.
What is Sotera Health Company (SHC)'s stock forecast?
Analysts predict Sotera Health Company stock to fluctuate between $9.53 (low) and $17.08 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Sotera Health Company's market capitalization?
As of 2025-05-28, Sotera Health Company's market cap is $3,463,031,000, based on 283,855,000 outstanding shares.
How does Sotera Health Company compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Sotera Health Company has a Lower Market-Cap, indicating a difference in performance.
How can I buy Sotera Health Company (SHC) stock?
To buy Sotera Health Company (SHC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SHC. Place an order (Market, Limit, etc.).
What is the best time to invest in Sotera Health Company?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Sotera Health Company perform in the last earnings report?
Revenue: $1,100,441,000 | EPS: $0.16 | Growth: -11.11%.
Where can I find Sotera Health Company's investor relations reports?
Visit https://soterahealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Sotera Health Company?
You can explore historical data from here
What is the all-time high and low for Sotera Health Company stock?
All-time high: $30.38 (2021-03-15) | All-time low: $5.78 (2022-11-09).
What are the key trends affecting Sotera Health Company stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Sotera Health Company (NASDAQ:SHC ) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Michael Petras - Chairman, Chief Executive Officer Jonathan Lyons - Chief Financial Officer Jason Peterson - Vice President of Investor Relations and Treasurer Conference Call Participants Patrick Donnelly - Citi Brett Fishbin - KeyBanc Matt Sykes - Goldman Sachs Luke Sergott - Barclays Dave Windley - Jefferies Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning. And welcome to the Sotera Health First Quarter of 2025 Earnings Call.
zacks.com
Sotera Health Company (SHC) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.13 per share a year ago.
globenewswire.com
CLEVELAND, May 01, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025.
globenewswire.com
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights.
zacks.com
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.
seekingalpha.com
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.
seekingalpha.com
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.
zacks.com
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago.
globenewswire.com
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.
See all news
